The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 4, pp. 435-437.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holtzer, C.
Right arrow Articles by Reisner-Keller, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holtzer, C.
Right arrow Articles by Reisner-Keller, L.


Research Articles

Phenytoin-induced thrombocytopenia

CD Holtzer and LA Reisner-Keller

OBJECTIVE: To describe a patient with severe thrombocytopenia induced by the administration of phenytoin for prevention of seizures. A review of the literature supplements this case description to alert clinicians to this potentially serious hematologic reaction. CASE SUMMARY: A woman who had experienced two seizures was prescribed phenytoin to prevent seizure recurrence. Further evaluation revealed a tumor, which was resected, and phenytoin was continued. Thrombocytopenia was noted 15 days after initiation of phenytoin, which was replaced with phenobarbital. Platelet transfusion and administration of intravenous immune globulin were used to treat her thrombocytopenia. Platelets were within the normal range by day 8 after the operation. DISCUSSION: Phenytoin has been reported to induce various hematologic reactions, including thrombocytopenia. An intermediate epoxide metabolite of phenytoin is suspected as the cause of platelet destruction, which may occur via a complement-antibody reaction. Our patient experienced some confusion as a possible consequence of her thrombocytopenia, but no long-term sequelae followed. CONCLUSIONS: Due to widespread use of phenytoin, clinicians must recognize the potential for the rare but serious adverse effect of thrombocytopenia, particularly in the neurosurgical population. Confusion, as observed in our patient, makes postoperative evaluation of central nervous system and cognitive function difficult, and can obscure the clinical presentation. At its worst extreme, disruption of platelet function may produce cerebral hemorrhage, which results in long-term functional deficits.


This article has been cited by other articles:


Home page
JBJSHome page
R. L. Ferguson
Medical and Congenital Comorbidities Associated with Spinal Deformities in the Immature Spine
J. Bone Joint Surg. Am., February 1, 2007; 89(suppl_1): 34 - 41.
[Full Text] [PDF]


Home page
J Child NeurolHome page
F. K. Alehan, E. C. Russell, and J. M. Pellock
Phenytoin-Associated Thrombocytopenia in a Toddler
J Child Neurol, February 1, 1999; 14(2): 130 - 131.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.